The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke

The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke

Item
http://www.wikidata.org/entity/Q26800181
MSC-derived Extracellular Vesicles Attenuate Immune Responses in Two Autoimmune Murine Models: Type 1 Diabetes and Uveoretinitis.Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials.Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.Clumping and Viability of Bone Marrow Derived Mesenchymal Stromal Cells under Different Preparation Procedures: A Flow Cytometry-Based In Vitro StudyCell therapies administered in the chronic phase after stroke: a meta-analysis examining safety and efficacy.Concise Review: Increasing the Validity of Cerebrovascular Disease Models and Experimental Methods for Translational Stem Cell Research.Concise Review: MSC Adhesion Cascade-Insights into Homing and Transendothelial Migration.The Current State of Cell Therapies for Cerebrovascular Diseases.Evaluation of Parametric Response Mapping to Assess Therapeutic Response to Human Mesenchymal Stem Cells after Experimental Stroke.In Vivo Long-Term Tracking of Neural Stem Cells Transplanted into an Acute Ischemic Stroke model with Reporter Gene-Based Bimodal MR and Optical Imaging.Cell Therapy in Stroke-Cautious Steps Towards a Clinical Treatment.Human Umbilical Cord Mesenchymal Stem Cells Preserve Adult Newborn Neurons and Reduce Neurological Injury after Cerebral Ischemia by Reducing the Number of Hypertrophic Microglia/Macrophages.The application of nanoparticles for neuroprotection in acute ischemic stroke.The Influence of Proinflammatory Factors on the Neuroprotective Efficiency of Multipotent Mesenchymal Stromal Cells in Traumatic Brain Injury.Serum-mediated Activation of Bone Marrow-derived Mesenchymal Stem Cells in Ischemic Stroke Patients: A Novel Preconditioning Method.Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cell, but not Adipose Tissue-Derived Stem Cell, Ameliorated the Neonatal Hypoxic-Ischemic Brain Injury by Changing Cerebral Inflammatory State in Rat
P2860

The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke

Item
http://www.wikidata.org/entity/Q26800181
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke
@ast
The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke
@en
The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke
@nl
type
label
The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke
@ast
The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke
@en
The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke
@nl
prefLabel
The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke
@ast
The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke
@en
The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P478
P50
P577
P5875
P698
P932
P3181
P356
P1433
P1476
The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke
@en
P2093
P2860
P304
P31
P3181
P356
P407
P478
P50
P577
P5875
P698
P932